Pharsight

Drugs that contain Methylphenidate

1. Cotempla Xr-odt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8840924 NEOS THERAPS INC Compositions and methods of making rapidly dissolving ionically masked formulations
Jun, 2026

(2 years from now)

US9089496 NEOS THERAPS INC Compositions comprising methylphenidate complexed with ion-exchange resin particles
Jun, 2032

(8 years from now)

US9072680 NEOS THERAPS INC Compositions comprising methylphenidate complexed with ion-exchange resin particles
Jun, 2032

(8 years from now)

US11166947 NEOS THERAPS INC Effective dosing of a child for the treatment of ADHD with methylphenidate
Jan, 2038

(13 years from now)

Market Authorisation Date: 19 June, 2017

Treatment: Treatment of attention deficit hyperactivity disorder (adhd) in pediatric patients

Dosage: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL

How can I launch a generic of COTEMPLA XR-ODT before it's drug patent expiration?
More Information on Dosage

COTEMPLA XR-ODT family patents

Family Patents

2. Daytrana patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8632802 NOVEN PHARMS INC Device for transdermal administration of drugs including acrylic polymers
Oct, 2025

(1 year, 7 months from now)

US9034370 NOVEN PHARMS INC Device for transdermal administration of drugs including acrylic polymers
Oct, 2025

(1 year, 7 months from now)

US9668981 NOVEN PHARMS INC Device for transdermal administration of drugs including acrylic based polymers
Oct, 2025

(1 year, 7 months from now)

Market Authorisation Date: 06 April, 2006

Treatment: Method for transdermally delivering a drug to a user in need thereof

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

How can I launch a generic of DAYTRANA before it's drug patent expiration?
More Information on Dosage

DAYTRANA family patents

Family Patents